论文部分内容阅读
随着流行性出血热(EHF)病毒的发现,寻求本病有效抗病毒药物已成为当今研究的重要课题。近年来已有用病毒唑治疗EHF的报道。现将我们用国产病毒唑治疗EHF临床疗效总结如下: 材料与方法 1.病例选择:为1989年9月至1990年2月颖上县王岗、六十铺区卫生院收治的晚期EHF(发病≤5天)住院病例,符合1986年全国EHF防治方案诊断标准,并经IFA检测证实。患者入院后随机分为病毒唑治疗组(治疗组)和对照组,两组病例在性别、年龄、入院病日及早期定度等具有可比性(见表1)。
With the discovery of epidemic hemorrhagic fever (EHF) virus, the search for an effective antiviral drug has become an important issue in today’s research. In recent years, treatment with ribavirin EHF has been reported. Now we use domestic Ribavirin EHF clinical efficacy are summarized as follows: Materials and methods 1. Case Selection: September 1989 to February 1990 Ying County Wang Gang, sixty shops in the hospital for treatment of advanced EHF (incidence ≤5 days) hospitalized cases, in line with the 1986 national EHF prevention and treatment programs diagnostic criteria, and confirmed by IFA test. Patients were randomly divided into ribavirin treatment group (treatment group) and control group after admission. The two groups were comparable in gender, age, admission date and early degree (Table 1).